Krystal Biotech, Inc. (KRYS): Shares Outstanding

Annual figures by period end, from SEC filings.

Figures left out. The filed Shares Outstanding for the year ended 2016-12-31 is not shown: zero share count.

29.19M
As of 2025-12-31
29.60M
As of 2026-06-30
+4.3%
3-year compound annual growth
+8.2%
5-year compound annual growth
2017-12-31: 10.31M2018-12-31: 14.43M2019-12-31: 17.35M2020-12-31: 19.71M2021-12-31: 25.21M2022-12-31: 25.76M2023-12-31: 28.24M2024-12-31: 28.79M2025-12-31: 29.19M29.19M
2017-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3129.19M+1.4%2026-02-17, Balance as of period end
2024-12-3128.79M+2.0%2026-02-17, Balance as of period end
2023-12-3128.24M+9.6%2025-02-19, Balance as of period end
2022-12-3125.76M+2.2%2024-02-26, Balance as of period end
2021-12-3125.21M+27.9%2023-02-27, Balance as of period end
2020-12-3119.71M+13.6%2022-02-28, Balance as of period end
2019-12-3117.35M+20.3%2021-03-01, Balance as of period end
2018-12-3114.43M+40.0%2020-03-10, Balance as of period end
2017-12-3110.31Mn/a2018-03-12, Balance as of period end